|
|
Volumn 45, Issue 3, 1989, Pages 220-225
|
|
Ferrous sulfate reduces levodopa bioavailability: Chelation as a possible mechanism
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FERROUS SULFATE;
LEVODOPA;
ADULT;
ANEMIA;
CHELATION;
DRUG BIOAVAILABILITY;
DRUG CHELATION;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
IRON THERAPY;
MALE;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
ADULT;
BIOLOGICAL AVAILABILITY;
DRUG INTERACTIONS;
FEMALE;
FERROUS COMPOUNDS;
HUMAN;
HYDROGEN-ION CONCENTRATION;
IRON CHELATING AGENTS;
LEVODOPA;
MALE;
OXIDATION-REDUCTION;
RANDOM ALLOCATION;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0024600260
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.1989.21 Document Type: Article |
|
Times cited : (32)
|
|
References (15)
|
